173 related articles for article (PubMed ID: 22895851)
21. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
Chrysant SG; Marbury TC; Silfani TN
Blood Press Monit; 2006 Jun; 11(3):135-41. PubMed ID: 16702822
[TBL] [Abstract][Full Text] [Related]
22. Multiway analysis methods applied to the fluorescence excitation-emission dataset for the simultaneous quantification of valsartan and amlodipine in tablets.
Dinç E; Ertekin ZC; Büker E
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Sep; 184():255-261. PubMed ID: 28514719
[TBL] [Abstract][Full Text] [Related]
23. Second-derivative synchronous spectrofluorimetric determination of nebivolol hydrochloride and amlodipine besylate in their combined dosage form.
Ibrahim F; El-Enany N; Shalan SH; Abo Shabana RA
Luminescence; 2015 Nov; 30(7):1011-9. PubMed ID: 25727077
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous determination of amlodipine and metoprolol in their combined dosage form using a synchronous fluorescence spectrofluorimetric method.
Mabrouk MM; Hammad SF; El-Malla SF; Elshenawy EA
Luminescence; 2018 Mar; 33(2):364-369. PubMed ID: 29071785
[TBL] [Abstract][Full Text] [Related]
25. Different Approaches in Manipulating Ratio Spectra for Analyzing Amlodipine Besylate and Irbesartan Combination.
El Mously DA; Mostafa NM; Hassan NY; El-Sayed GM
J AOAC Int; 2022 Sep; 105(5):1219-1227. PubMed ID: 35689609
[TBL] [Abstract][Full Text] [Related]
26. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.
Ram CV
Curr Med Res Opin; 2009 Jan; 25(1):177-85. PubMed ID: 19210150
[TBL] [Abstract][Full Text] [Related]
27. Comparative ANNs with different input layers and GA-PLS study for simultaneous spectrofluorimetric determination of melatonin and pyridoxine HCl in the presence of melatonin’s main impurity.
Darwish HW; Attia MI; Abdelhameed AS; Alanazi AM; Bakheit AH
Molecules; 2013 Jan; 18(1):974-96. PubMed ID: 23344205
[TBL] [Abstract][Full Text] [Related]
28. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Volpe M; Christian Rump L; Ammentorp B; Laeis P
Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
[TBL] [Abstract][Full Text] [Related]
30. Validated spectrofluorometric methods for determination of amlodipine besylate in tablets.
Abdel-Wadood HM; Mohamed NA; Mahmoud AM
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Aug; 70(3):564-70. PubMed ID: 17889593
[TBL] [Abstract][Full Text] [Related]
31. Steady-state and synchronous spectrofluorimetric methods for simultaneous determination of aliskiren hemifumarate and amlodipine besylate in dosage forms.
Ebeid WM; Elkady EF; El-Zaher AA; El-Bagary RI; Patonay G
Luminescence; 2014 Nov; 29(7):878-83. PubMed ID: 24687516
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments.
Marisetti VM; Katakam P; Siddhani VK; Katari NK
Biomed Chromatogr; 2021 Nov; 35(11):e5194. PubMed ID: 34110035
[TBL] [Abstract][Full Text] [Related]
33. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
Chrysant SG
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of highly Sensitive Stability Indicating Spectrofluorimetric Method for Determination of Amlodipine in Pharmaceutical Preparations and Human Plasma.
Mohamed AI; Omar MA; Hammad MA; Mohamed AA
J Fluoresc; 2016 Nov; 26(6):2141-2149. PubMed ID: 27566613
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets.
Hassan SA; Elzanfaly ES; El-Zeany SB; Salem MY
Acta Pharm; 2016 Dec; 66(4):479-490. PubMed ID: 27749253
[TBL] [Abstract][Full Text] [Related]
36. Olmesartan/amlodipine: a review of its use in the management of hypertension.
Kreutz R
Vasc Health Risk Manag; 2011; 7():183-92. PubMed ID: 21490944
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females.
Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q
Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920
[TBL] [Abstract][Full Text] [Related]
38. RP-HPLC-DAD method for determination of olmesartan medoxomil in bulk and tablets exposed to forced conditions.
Sharma RN; Pancholi SS
Acta Pharm; 2010 Mar; 60(1):13-24. PubMed ID: 20228038
[TBL] [Abstract][Full Text] [Related]
39. Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of Amlodipine and Atorvastatin.
Darwish HW; Hassan SA; Salem MY; El-Zeiny BA
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Dec; 83(1):140-8. PubMed ID: 21908232
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
Chrysant SG; Marbury TC; Robinson TD
J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
